ea0049ep203 | Neuroendocrinology | ECE2017
Lages Adriana
, Moreira Helder
, Costa Gracinda
, Oliveira Patricia
, Oliveira Diana
, Martins Diana
, Ventura Mara
, Cunha Nelson
, Carrilho Francisco
Introduction and purpose: 177Lu-[DOTA0,Tyr3]octreotate (177Lu-DOTA-TATE) is a radiopharmaceutical frequently used in peptide receptor radionuclide therapy (PRRT), which is a promising treatment modality in patients with metastasized neuroendocrine tumors (NETs). We purpose to evaluate the quality of life (QoL) in patients with somatostatin receptor positive inoperable or metastatic NETs throughout the three cycles (with three months intervals) proto...